Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.51
+3.20 (1.38%)
AAPL  249.42
+1.77 (0.71%)
AMD  253.78
+3.98 (1.59%)
BAC  52.63
+0.56 (1.09%)
GOOG  331.54
+3.16 (0.96%)
META  646.70
+33.74 (5.50%)
MSFT  450.67
+6.56 (1.48%)
NVDA  184.59
+1.27 (0.69%)
ORCL  178.45
+4.57 (2.63%)
TSLA  447.68
+16.24 (3.76%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.